Abbott Laboratories

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$110.83

+1.75 (+1.60%)

As of Feb 12, 6:31 PM ET ·

Income Statement

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Revenue	44.07B	43.85B	37.56B	33.22B	38.26B
Net Income	6.49B	5.81B	6.99B	6.02B	6.40B
EPS	—	—	—	—	—
Profit Margin	14.7%	14.0%	18.6%	18.1%	16.7%
Rev Growth	+0.5%	+0.5%	+21.8%	+10.5%	-2.3%

Balance Sheet

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Total Debt	22.03B	22.03B	28.35B	25.40B	31.10B
Total Equity	74.33B	74.33B	107.24B	104.22B	116.10B
D/E Ratio	0.30	0.30	0.26	0.24	0.27

Cash Flow

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
EBITDA	10.22B	9.66B	10.80B	10.39B	11.25B
Free Cash Flow	—	—	4.88B	6.26B	6.35B